MacCarthy Sarah, Poteat Tonia, Xia Zhiyu, Roque Nicolette L, Hyun Jin Kim Ashley, Baral Stefan, Reisner Sari L
RAND Corporation, 1776 Main Street, Santa Monica, CA 90407, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615N. Wolfe Street, Baltimore, MD 21205, USA.
Sex Health. 2017 Oct;14(5):456-468. doi: 10.1071/SH17096.
Transgender populations are heavily burdened by HIV and other sexually transmissible infections (STIs). However, data on co-infection with HIV and STIs among transgender people are limited. A systematic review was conducted of peer-reviewed articles and conference abstracts between January 2010 and November 2015 that focussed on HIV and STI infections among transgender populations globally. The literature was synthesised and opportunities for improving health research were commented on. Few studies reported HIV-STI co-infection (n=4), while the majority of studies reported HIV and STI infections separately (n=23). Most studies were conducted outside of the USA (n=19), and all but one of these studies reported data on transgender women only. Among USA-based studies (n=8), several reported data on both transgender men and transgender women (n=3), whereas other studies reported exclusively on transgender men (n=1) or transgender women (n=4). Understanding HIV and STIs among transgender people requires research that simultaneously considers multilevel drivers of vulnerabilities. More data are needed on how the interaction of individual determinants, including biological risks of transmission, programmatic determinants such as service-delivery models and policy-level determinants including institutionalised stigma in healthcare settings, influence the HIV- and STI-related outcomes of transgender populations. Leveraging the knowledge of transgender-specific determinants of HIV and STIs should guide the content and approaches to future HIV and STI prevention and treatment efforts.
跨性别群体承受着艾滋病病毒(HIV)和其他性传播感染(STIs)的沉重负担。然而,关于跨性别者中HIV与STIs合并感染的数据有限。对2010年1月至2015年11月期间聚焦全球跨性别群体中HIV和STIs感染情况的同行评审文章及会议摘要进行了系统综述。对文献进行了综合分析,并对改善健康研究的机会进行了评论。很少有研究报告HIV-STIs合并感染情况(n = 4),而大多数研究分别报告了HIV和STIs感染情况(n = 23)。大多数研究在美国境外开展(n = 19),且除一项研究外,这些研究均仅报告了跨性别女性的数据。在美国开展的研究中(n = 8),有几项报告了跨性别男性和跨性别女性的数据(n = 3),而其他研究仅报告了跨性别男性(n = 1)或跨性别女性(n = 4)的数据。了解跨性别者中的HIV和STIs需要开展同时考虑多层次脆弱性驱动因素的研究。需要更多数据来了解个体决定因素(包括传播的生物学风险)、项目决定因素(如服务提供模式)以及政策层面决定因素(包括医疗环境中的制度化耻辱感)之间的相互作用如何影响跨性别群体与HIV和STIs相关的结果。利用对跨性别者特有的HIV和STIs决定因素的了解,应指导未来HIV和STIs预防及治疗工作的内容和方法。